A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

NCT05487170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
DLBCL

Interventions

DRUG: RNK05047

Sponsor

Ranok Therapeutics (Hangzhou) Co., Ltd.